Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum-resistant Ovarian Cancer
NCT02659384Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 2016
- Primary completion
- Jun 2021
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of atezolizumab in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 2016; status: completed.
02
Drugs
atezolizumab
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02659384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659384.